| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| GCY |
|
growth control, Y chromosome influenced
|
|
|
0.631 |
0.615 |
| GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| SAA3P |
|
serum amyloid A3, pseudogene
|
|
|
0.722 |
0.500 |
| TRA |
P0DSE1
|
T cell receptor alpha locus
|
|
|
0.628 |
0.577 |
| TRB |
P0DSE2
|
T cell receptor beta locus
|
|
|
0.636 |
0.538 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| HSP90B2P |
Q58FF3
|
heat shock protein 90 beta family member 2, pseudogene
|
Chaperone
|
|
0.558 |
0.846 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| TRBV16 |
A0A087WV62
|
T cell receptor beta variable 16 (gene/pseudogene)
|
|
|
0.695 |
0.500 |
| TRBV7-9 |
P04435
|
T cell receptor beta variable 7-9
|
|
|
0.695 |
0.500 |
| TRBC1 |
P01850
|
T cell receptor beta constant 1
|
|
|
0.695 |
0.500 |